Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term Treatment With Tenofovir Alafenamide for Chronic Hepatitis B Results in High Rates of Viral Suppression and Favorable Renal and Bone Safety.
Chan HLY, Buti M, Lim YS, Agarwal K, Marcellin P, Brunetto M, Chuang WL, Janssen HLA, Fung S, Izumi N, Abdurakhmanov D, Jabłkowski M, Celen MK, Ma X, Caruntu F, Flaherty JF, Abramov F, Wang H, Camus G, Osinusi A, Pan CQ, Shalimar D, Seto WK, Gane E. Chan HLY, et al. Among authors: jablkowski m. Am J Gastroenterol. 2023 Aug 10;119(3):486-96. doi: 10.14309/ajg.0000000000002468. Online ahead of print. Am J Gastroenterol. 2023. PMID: 37561058 Free PMC article.
Atherosclerotic cardiovascular disease risk profile of patients with chronic hepatitis B treated with tenofovir alafenamide or tenofovir disoproxil fumarate for 96 weeks.
Fung SK, Pan CQ, Wong GL, Seto WK, Ahn SH, Chen CY, Hann HL, Jablkowski MS, Kim YJ, Yurdaydin C, Peng CY, Nguyen T, Yatsuhashi H, Flaherty JF, Yee LJ, Abramov F, Wang H, Abdurakhmanov D, Lim YS, Buti M. Fung SK, et al. Among authors: jablkowski ms. Aliment Pharmacol Ther. 2024 Jan;59(2):217-229. doi: 10.1111/apt.17764. Epub 2023 Oct 31. Aliment Pharmacol Ther. 2024. PMID: 37905449
Controlled attenuation parameter for the assessment of fatty liver in patients with type 1 diabetes mellitus: which cutoffs to choose? Authors' reply.
Grzelka-Woźniak A, Uruska A, Szymańska-Garbacz E, Araszkiewicz A, Jabłkowski M, Czupryniak L, Zozulińska-Ziółkiewicz D. Grzelka-Woźniak A, et al. Among authors: jablkowski m. Pol Arch Intern Med. 2024 Jan 29;134(1):16614. doi: 10.20452/pamw.16614. Epub 2024 Jan 29. Pol Arch Intern Med. 2024. PMID: 38284874 Free article. No abstract available.
Indirect insulin resistance markers in relation to nonalcoholic fatty liver disease among patients with type 1 diabetes mellitus. Authors' reply.
Grzelka-Woźniak A, Uruska A, Szymańska-Garbacz E, Araszkiewicz A, Jabłkowski M, Czupryniak L, Zozulińska-Ziółkiewicz D. Grzelka-Woźniak A, et al. Among authors: jablkowski m. Pol Arch Intern Med. 2023 Aug 30;133(7-8):16553. doi: 10.20452/pamw.16553. Epub 2023 Aug 30. Pol Arch Intern Med. 2023. PMID: 37646594 Free article. No abstract available.
Right-left digit ratios, a novel form of asymmetry: Patterns of instability in children and relationships to platelet counts and hospitalization in adults with COVID-19.
Kasielska-Trojan A, Manning JT, Jabłkowski M, Białkowska-Warzecha J, Kwasniewska O, Hirschberg AL, Antoszewski B. Kasielska-Trojan A, et al. Among authors: jablkowski m. Front Public Health. 2022 Oct 14;10:995025. doi: 10.3389/fpubh.2022.995025. eCollection 2022. Front Public Health. 2022. PMID: 36311570 Free PMC article.
69 results